HIGHLIGHTS
- who: Chiara Fischer et al. from the Department of Obstetrics and Gynecology, University of Heidelberg, Im Neuenheimer Feld, Heidelberg, Germany have published the research work: Circulating miR-200 Family and CTCs in Metastatic Breast Cancer before, during, and after a New Line of Systemic Treatment, in the Journal: (JOURNAL)
- what: The authors evaluated levels of circulating EMT-related miR-200 members in blood plasma over the course of MBC and assessed the capacity of these miRNAs to serve as clinical biomarkers for MBC, along with the corresponding CTC status. The present analysis was a retrospective . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.